Literature DB >> 12611783

Effects of a branched-chain amino acid drink in mania.

A Scarna1, H J Gijsman, S F B McTavish, C J Harmer, P J Cowen, G M Goodwin.   

Abstract

BACKGROUND: Administration of a complex tyrosine-free amino acid drink acutely decreases manic symptoms. Although a nutrient-based approach to illness management is attractive, complex amino acid drinks are too unpalatable for repeated administration. AIMS: To assess whether a simple, branched-chain amino acid (BCAA) drink diminishes manic symptoms acutely and following repeated administration.
METHOD: Twenty-five patients with mania were randomly and blindly allocated to treatment with BCAA (60 g) or placebo daily for 7 days.
RESULTS: Relative to placebo, the BCAA drink lowered mania ratings acutely over the first 6 h of treatment. In protocol completers there was a persistent advantage to the BCAA group 1 week after the end of treatment.
CONCLUSIONS: A nutritional intervention that decreases tyrosine availability to the brain acutely ameliorates manic symptoms. Further studies are required to assess whether this approach has longer-term efficacy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12611783     DOI: 10.1192/bjp.182.3.210

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  23 in total

1.  An Untargeted Metabolomics Analysis of Antipsychotic Use in Bipolar Disorder.

Authors:  Kyle J Burghardt; Simon J Evans; Kristen M Wiese; Vicki L Ellingrod
Journal:  Clin Transl Sci       Date:  2015-08-27       Impact factor: 4.689

2.  Appropriate amino acid mixtures for tryptophan depletion and tyrosine/phenylalanine depletion and the safety of long-term amino acid depletion in humans.

Authors:  Simon N Young
Journal:  Psychopharmacology (Berl)       Date:  2013-08-13       Impact factor: 4.530

3.  Polypharmacy, multiple natural health products and hepatotoxicity.

Authors:  Kosta Cvijovic; Heather Boon; Walter Jaeger; Sunita Vohra
Journal:  CMAJ       Date:  2011-07-04       Impact factor: 8.262

4.  Acute lithium administration selectively lowers tyrosine levels in serum and brain.

Authors:  Hewlet G McFarlane; John Steele; Keenan Vinion; Rodolfo Bongiovanni; Manda Double; George E Jaskiw
Journal:  Brain Res       Date:  2011-08-27       Impact factor: 3.252

Review 5.  Novel nutritional treatment for manic and psychotic disorders: a review of tryptophan and tyrosine depletion studies and the potential of protein-based formulations using glycomacropeptide.

Authors:  Abdulla Badawy
Journal:  Psychopharmacology (Berl)       Date:  2013-07-05       Impact factor: 4.530

6.  Clozapine-induced dopamine release in the medial prefrontal cortex is augmented by a moderate concentration of locally administered tyrosine but attenuated by high tyrosine concentrations or by tyrosine depletion.

Authors:  George E Jaskiw; Bobbi Kirkbride; Erica Newbould; Damon Young; Valerie Durkalski; Rodolfo Bongiovanni
Journal:  Psychopharmacology (Berl)       Date:  2005-01-29       Impact factor: 4.530

7.  Mood-elevating effects of d-amphetamine and incentive salience: the effect of acute dopamine precursor depletion.

Authors:  Marco Leyton; Marije aan het Rot; Linda Booij; Glen B Baker; Simon N Young; Chawki Benkelfat
Journal:  J Psychiatry Neurosci       Date:  2007-03       Impact factor: 6.186

8.  Specificity of the acute tryptophan and tyrosine plus phenylalanine depletion and loading tests I. Review of biochemical aspects and poor specificity of current amino Acid formulations.

Authors:  Abdulla A-B Badawy; Donald M Dougherty; Dawn M Richard
Journal:  Int J Tryptophan Res       Date:  2010-01-01

9.  In rats chronically treated with clozapine, tyrosine depletion attenuates the clozapine-induced in vivo increase in prefrontal cortex dopamine and norepinephrine levels.

Authors:  George E Jaskiw; Bobbi Kirkbride; Rodolfo Bongiovanni
Journal:  Psychopharmacology (Berl)       Date:  2006-03-16       Impact factor: 4.530

Review 10.  Elevated reward-related neural activation as a unique biological marker of bipolar disorder: assessment and treatment implications.

Authors:  Robin Nusslock; Christina B Young; Katherine S F Damme
Journal:  Behav Res Ther       Date:  2014-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.